Home › Funds › DIADEMA PARTNERS LP › PTHS

DIADEMA PARTNERS LP position in PTHS

PELTHOS THERAPEUTICS INC · Health Care

DIADEMA PARTNERS LP reported holding 80,760 shares of PTHS (PELTHOS THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$1.7M, representing 0.46% of its reported portfolio and ranking #45 among its reported holdings. DIADEMA PARTNERS LP has disclosed PTHS holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)80.76K sh
Reported value held$1.70M
Portfolio Weight0.46%
First reportedQ3 2025
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How DIADEMA PARTNERS LP's PTHS position evolved

DIADEMA PARTNERS LP first disclosed a stake in PTHS in Q3 2025 at 10,498 shares (US$294K). The position peaked in Q3 2026 at 80,760 shares, worth US$1.7M. Across 5 filings, DIADEMA PARTNERS LP increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 80,760 shares valued at US$1.7M — an increase of 55,987 shares quarter over quarter.. Notable position changes include a 138% increase in Q4 2025 (shares fell 32% over the following quarter), a 226% increase in Q3 2026 (shares fell 65% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 10.50K $293.94K New
Q4 2025 25.00K $775.00K Add
Q1 2026 24.77K $520.48K Reduce
Q2 2026 24.77K $700.09K Hold
Q3 2026 80.76K $1.70M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PTHS and 13F data

PTHS (PELTHOS THERAPEUTICS INC) is a Health Care company. 29 other funds we track also report a position in PTHS — the largest reported positions include Ikarian Capital, LLC (US$7.3M), Murchinson Ltd. (US$6.5M), AIGH Capital Management LLC (US$5.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PTHS

All PTHS fund holders →

FAQ

How long has DIADEMA PARTNERS LP held PTHS?

DIADEMA PARTNERS LP has disclosed PTHS holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is DIADEMA PARTNERS LP's current position in PTHS?

As of Q3 2026, DIADEMA PARTNERS LP holds 80.76K shares of PTHS (PELTHOS THERAPEUTICS INC), valued at $1.70M, representing 0.46% of its reported portfolio and ranking #45.

Has DIADEMA PARTNERS LP been buying or selling PTHS?

In the latest 13F filing (Q3 2026), DIADEMA PARTNERS LP increased its position in PTHS. The position peaked in Q3 2026 at 80.76K shares.

Which other funds hold PTHS?

Other major institutional holders of PTHS include Ikarian Capital, LLC, Murchinson Ltd., AIGH Capital Management LLC, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.